JPWO2022004054A1 - - Google Patents
Info
- Publication number
- JPWO2022004054A1 JPWO2022004054A1 JP2022533676A JP2022533676A JPWO2022004054A1 JP WO2022004054 A1 JPWO2022004054 A1 JP WO2022004054A1 JP 2022533676 A JP2022533676 A JP 2022533676A JP 2022533676 A JP2022533676 A JP 2022533676A JP WO2022004054 A1 JPWO2022004054 A1 JP WO2022004054A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025085915A JP2025109968A (ja) | 2020-06-30 | 2025-05-22 | Ｓｔａｔ３のリン酸化抑制剤、自己免疫疾患及びコロナウイルス感染症の予防又は治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020112680 | 2020-06-30 | ||
| JP2020112680 | 2020-06-30 | ||
| PCT/JP2021/007780 WO2022004054A1 (ja) | 2020-06-30 | 2021-03-01 | Ｓｔａｔ３のリン酸化抑制剤、自己免疫疾患及びコロナウイルス感染症の予防又は治療剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085915A Division JP2025109968A (ja) | 2020-06-30 | 2025-05-22 | Ｓｔａｔ３のリン酸化抑制剤、自己免疫疾患及びコロナウイルス感染症の予防又は治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022004054A1 true JPWO2022004054A1 (https=) | 2022-01-06 |
| JP7702150B2 JP7702150B2 (ja) | 2025-07-03 |
Family
ID=79315687
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533676A Active JP7702150B2 (ja) | 2020-06-30 | 2021-03-01 | Ｓｔａｔ３のリン酸化抑制剤、自己免疫疾患及びコロナウイルス感染症の予防又は治療剤 |
| JP2025085915A Pending JP2025109968A (ja) | 2020-06-30 | 2025-05-22 | Ｓｔａｔ３のリン酸化抑制剤、自己免疫疾患及びコロナウイルス感染症の予防又は治療剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085915A Pending JP2025109968A (ja) | 2020-06-30 | 2025-05-22 | Ｓｔａｔ３のリン酸化抑制剤、自己免疫疾患及びコロナウイルス感染症の予防又は治療剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230201310A1 (https=) |
| EP (1) | EP4194004A4 (https=) |
| JP (2) | JP7702150B2 (https=) |
| CN (1) | CN115835879A (https=) |
| WO (1) | WO2022004054A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114732831B (zh) * | 2022-04-25 | 2023-06-23 | 齐鲁理工学院 | 斯钙素-1作为调节肿瘤微环境的标志物的应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013008681A1 (ja) * | 2011-07-09 | 2013-01-17 | 国立大学法人東北大学 | 線維症予防又は治療用医薬組成物 |
| JP2016520583A (ja) * | 2013-05-10 | 2016-07-14 | オルフス ユニバーシテト | パッパリシンレギュレーター |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2387685A1 (en) * | 1999-10-27 | 2001-05-03 | Human Genome Sciences, Inc. | Stanniocalcin proteins and nucleic acids and methods based thereon |
| US8759298B2 (en) * | 2010-05-03 | 2014-06-24 | Scott & White Healthcare | Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration |
-
2021
- 2021-03-01 WO PCT/JP2021/007780 patent/WO2022004054A1/ja not_active Ceased
- 2021-03-01 US US17/925,974 patent/US20230201310A1/en active Pending
- 2021-03-01 JP JP2022533676A patent/JP7702150B2/ja active Active
- 2021-03-01 EP EP21833677.4A patent/EP4194004A4/en active Pending
- 2021-03-01 CN CN202180035683.2A patent/CN115835879A/zh active Pending
-
2025
- 2025-05-22 JP JP2025085915A patent/JP2025109968A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013008681A1 (ja) * | 2011-07-09 | 2013-01-17 | 国立大学法人東北大学 | 線維症予防又は治療用医薬組成物 |
| JP2016520583A (ja) * | 2013-05-10 | 2016-07-14 | オルフス ユニバーシテト | パッパリシンレギュレーター |
Non-Patent Citations (8)
| Title |
|---|
| BONFANTE, S. ET AL.: " Stanniocalcin 1 Inhibits the Inflammatory Response in Microglia and Protects Against Sepsis-Associa", NEUROTOXICITY RESEARCH, vol. 39, JPN6021014808, 6 October 2020 (2020-10-06), pages 119 - 132, ISSN: 0005613982 * |
| CYTOKINE: X, vol. Vol. 2, No. 2, 100029, JPN6025011369, 14 May 2020 (2020-05-14), pages 1 - 7, ISSN: 0005557831 * |
| FREE RADICAL BIOLOGY AND MEDICINE, vol. 71, JPN6025011371, 2014, pages 321 - 331, ISSN: 0005613984 * |
| HUANG, L. ET AL.: "Stanniocalcin-1 inhibits thrombin-induced signaling and protects from bleomycin-induced lung injury", SCIENTIFIC REPORTS, vol. 5, JPN6021014805, 2015, pages 18117 - 1, XP055897675, ISSN: 0005613980, DOI: 10.1038/srep18117 * |
| INNOVATIVE MEDICINE, JPN6025011367, 2015, pages 131 - 147, ISSN: 0005557830 * |
| WU, Y. ET AL.: "Upregulation of stanniocalcin‐1 inhibits the development of osteoarthritis by inhibiting survival a", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 120, JPN6021014803, 2019, pages 9768 - 9780, XP055897674, ISSN: 0005557829, DOI: 10.1002/jcb.28257 * |
| ZHAO, J. ET AL.: "Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling", FRONTIERS IN PHYSIOLOGY, vol. Vol. 9, Article 873, JPN6021014806, 2018, pages 1 - 8, ISSN: 0005613981 * |
| ウイルス, vol. 69, no. 1, JPN6025011370, 2019, pages 61 - 72, ISSN: 0005613983 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7702150B2 (ja) | 2025-07-03 |
| US20230201310A1 (en) | 2023-06-29 |
| JP2025109968A (ja) | 2025-07-25 |
| CN115835879A (zh) | 2023-03-21 |
| EP4194004A1 (en) | 2023-06-14 |
| WO2022004054A1 (ja) | 2022-01-06 |
| TW202207972A (zh) | 2022-03-01 |
| EP4194004A4 (en) | 2024-07-24 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250325 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250512 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250610 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250616 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7702150 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |